The Oncopig Model
The Oncopig Cancer Model is an inducible translational porcine model that develops clinically relevant tumors at defined locations and timepoints.
The Oncopig Cancer Model combined with our proprietary pig-based preclinical testing services provides the benefit of reducing false positives, modeling the interactions of multiple diseases, and accelerating progress towards human clinical trials. Our patent-pending technology allows us to induce tumors in specific sites in combination with clinically relevant comorbidities. As a result, we can work with individualized models and tumors harboring custom designed genetic modifications. Our technology has the ability to not only efficiently and effectively undergo preclinical trials, but allows us to eliminate logistical and accrual barriers associated with clinical trials, such as gender, pregnancy, age, and comorbidities.